“codiak-biosciences” Archives

in
Entry Author Date Location
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin 10/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak 07/17/19 Texas
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies 09/10/18 San Francisco
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M 11/29/17 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Codiak BioSciences Receives $61,000,000 Series B Financing Round 01/26/16 Boston
Key for Houston’s Biotech Ecosystem? Building a Bench of Executives 12/07/15 Texas
Roundup: Station Houston, Launch Health, Pryor Medical, DEC, Fannin 11/23/15 Texas
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Codiak BioSciences Obtains $80,000,000 Series A Financing Round 11/18/15 San Francisco
Doug Williams, Codiak at Today’s Health Summit: Last Chance for Tix 11/17/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Page 1 of 1